 |
市场调查报告书
商品编码
1420259
美国数位医疗解决方案的成长机会，以实现基于价值的护理Growth Opportunities in US Digital Health Solutions as an Enabler for Value-based Care |
||||||
稳健的投资和颠覆性创新将改变护理服务
根据医疗保险和医疗补助服务中心 (CMS) 的说法，基于价值的护理 (VBC) 计划根据医疗保健提供者向医疗保险患者提供的护理品质向他们提供奖励。
这些计划是 CMS 改革医疗保健服务和支付的品质策略的一部分。以价值为基础的计画支持三个目标：为个人提供更好的照护、为人群提供更好的健康、降低照护成本。本研究分析了支持 VBC 计划的支付者和提供者（包括医生诊所和医院）的数位健康解决方案。我们排除针对生命科学、製药公司和上市公司的解决方案。评估目标仅限于美国，基于CMS来考虑概念。
本研究涵盖了 CMS 基于价值的计划和支付奖励的现状，包括 ACO REACH、MSSP、MCP 和 AHEAD 模型，以及未来五年的监管更新和成长机会。此外，我们还评估了数位医疗提供者和付款人在数位品质衡量和绩效差距方面的作用，并重点介绍了美国现有企业和新兴企业透过数位医疗解决方案实现 VBC 的最佳实践。
目录
战略问题
- 为什么成长如此困难？
- The Strategic Imperative 8（TM）
- 关键策略要务对美国基于价值的护理 (VBC) 行业的影响
- 成长机会推动Growth Pipeline Engine（TM）
成长机会分析
- 分析范围
- 市场区隔
- 付款奖励- CMS VBC 模型
- 付款奖励-责任医疗模式
- 付款奖励-责任医疗模式：医疗保险共享储蓄计划 (MSSP)
- 付款奖励-责任医疗模型：ACO 实现公平、获取和社区健康 (ACO REACH) 模型
- 付款奖励-责任医疗模式
- 支付奖励－特定疾病和基于事件的模型
- 付款奖励- 2015 年医疗保险准入和 CHIP 再授权法案 (MACRA)：基于绩效的激励付款系统 (MIPS)
- 付款奖励- MACRA：替代付款模式 (APM)
- VBC程序和帐单
- 如何衡量品质
- 如何衡量品质 - 医疗保健品质的 6 个优先事项
- 如何衡量品质－数位健康的作用
- 如何衡量品质－付款人的角色
- 解决绩效衡量方面的差距
- 美国现有企业和新兴企业透过数位健康解决方案支持 VBC
- 生长促进因子
- 成长抑制因素
成长机会宇宙
- 成长机会 1：数字品质指标 (dQM) 标准化
- 成长机会 2：投资行为健康与远端保健
- 成长机会三：中小型诊所需求
- 成长机会 4：针对医师倦怠的生成式人工智慧
- 图表列表
- 免责声明
"Robust Investments and Disruptive Technological Innovation Transforming Care Delivery."
According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients.
These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: better care for individuals, better health for populations, and lower cost of care. This study analyzes digital health solutions for payers and providers (including physician practices and hospitals) that enable VBC programs. It excludes solutions targeting life sciences, pharmaceutical companies, and the public sector. Evaluations are exclusive to the United States, with concept considerations based on the CMS.
The study addresses the current status of value-based programs and payment incentives by CMS, such as ACO REACH, MSSP, MCP, and AHEAD models, alongside regulatory updates and growth opportunities for the next five years. It additionally assesses the role of digital health providers and payers in digital quality measurements and performance gaps, showcasing best practices from established US companies and start-ups enabling VBC through digital health solutions.
Table of Contents
Strategic Imperatives
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on the US Value-based Care (VBC) Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Opportunity Analysis
- Scope of Analysis
- Market Segmentation
- Payment Incentives-CMS VBC Models
- Payment Incentives-Accountable Care Models
- Payment Incentives-Accountable Care Models: Medicare Shared Savings Program (MSSP)
- Payment Incentives-Accountable Care Models: ACO Realizing Equity, Access, and Community Health (ACO REACH) Model
- Payment Incentives-Accountable Care Models
- Payment Incentives-Disease-specific and Episode-based Models
- Payment Incentives-Medicare Access and CHIP Reauthorization Act of 2015 (MACRA): Merit-based Incentive Payment System (MIPS)
- Payment Incentives-MACRA: Alternative Payment Models (APMs)
- VBC Programs and Legislation
- How to Measure Quality?
- How to Measure Quality?-The 6 Healthcare Quality Priorities
- How to Measure Quality?-Digital Health's Role
- How to Measure Quality?-Payer's Role
- Addressing Gaps in Performance Measurement
- Established US Companies and Start-ups Enabling VBC through Digital Health Solutions
- Growth Drivers
- Growth Restraints
Growth Opportunity Universe
- Growth Opportunity 1: Standardization of Digital Quality Measures (dQMs)
- Growth Opportunity 2: Behavioral Health and Telehealth Investment
- Growth Opportunity 3: Small and Medium Practices Demand
- Growth Opportunity 4: Generative AI for Physician Burnout
- List of Exhibits
- Legal Disclaimer
